Alimera Sciences Ownership 2024 | Who Owns Alimera Sciences Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

35.70%

Insider Ownership

5.97%

Retail Ownership

58.34%

Institutional Holders

17.00

Alimera Sciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CALIGAN PARTNERS LP	30.93%	17.36%	16,835,154	-	-	65,657,101	Mar 31, 2024
VELAN CAPITAL INVESTMENT MANAGEMENT LP	25.01%	24.10%	13,608,533	-	-	53,073,279	Mar 31, 2024
STONEPINE CAPITAL MANAGEMENT, LLC	7.44%	12.53%	4,051,072	51,613	1.29%	15,799,181	Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC	5.88%	0.24%	3,198,708	-	-	12,474,961	Mar 31, 2024
ALTIUM CAPITAL MANAGEMENT LP	4.69%	3.94%	2,550,000	-110,000	-4.14%	9,945,000	Mar 31, 2024
CLEARLINE CAPITAL LP	3.83%	0.40%	2,085,291	-83,852	-3.87%	8,132,635	Mar 31, 2024
AIGH CAPITAL MANAGEMENT LLC	2.79%	1.78%	1,520,359	-705,709	-31.70%	5,929,400	Mar 31, 2024
VANGUARD GROUP INC	1.92%	0.00%	1,045,460	396,506	61.10%	4,077,294	Mar 31, 2024
MORGAN STANLEY	0.92%	0.00%	501,738	-414,508	-45.24%	1,956,779	Mar 31, 2024
BLACKROCK INC.	0.89%	-	483,294	39,455	8.89%	1,884,847	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.69%	0.00%	378,237	46,260	13.93%	1,475,651	Mar 31, 2024
ANCORA ADVISORS, LLC	0.43%	0.02%	234,620	234,620	100.00%	915,018,000	Mar 31, 2024
BANK OF MONTREAL /CAN/	0.35%	0.00%	188,067	63,770	51.30%	757,910	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.32%	0.00%	174,794	16,000	10.08%	682,000	Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.26%	0.01%	139,100	119,100	595.50%	542,490	Mar 31, 2024
STATE STREET CORP	0.24%	-	133,016	133,016	100.00%	518,762	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	0.23%	0.00%	126,159	93,698	288.65%	492,020	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.20%	0.00%	107,101	107,101	100.00%	417,694	Mar 31, 2024
MARSHALL WACE, LLP	0.16%	0.00%	85,301	85,301	100.00%	332,674	Mar 31, 2024
NORTHERN TRUST CORP	0.13%	-	73,418	59,286	419.52%	286,330	Mar 31, 2024

Alimera Sciences's largest institutional shareholder is CALIGAN PARTNERS LP, holding 30.93% of the company's total share outstanding, currently valued at $65.66M. The top 10 institutional shareholders own together 84.30% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VELAN CAPITAL INVESTMENT MANAGEMENT LP	25.01%	24.10%	13,608,533	-	-	53,073,279	Mar 31, 2024
CALIGAN PARTNERS LP	30.93%	17.36%	16,835,154	-	-	65,657,101	Mar 31, 2024
STONEPINE CAPITAL MANAGEMENT, LLC	7.44%	12.53%	4,051,072	51,613	1.29%	15,799,181	Mar 31, 2024
ALTIUM CAPITAL MANAGEMENT LP	4.69%	3.94%	2,550,000	-110,000	-4.14%	9,945,000	Mar 31, 2024
AIGH CAPITAL MANAGEMENT LLC	2.79%	1.78%	1,520,359	-705,709	-31.70%	5,929,400	Mar 31, 2024
CLEARLINE CAPITAL LP	3.83%	0.40%	2,085,291	-83,852	-3.87%	8,132,635	Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC	5.88%	0.24%	3,198,708	-	-	12,474,961	Mar 31, 2024
FIFTH LANE CAPITAL, LP	0.04%	0.07%	21,238	21,238	100.00%	82,828	Mar 31, 2024
ANCORA ADVISORS, LLC	0.43%	0.02%	234,620	234,620	100.00%	915,018,000	Mar 31, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.	0.08%	0.01%	43,400	43,400	100.00%	169,260	Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.26%	0.01%	139,100	119,100	595.50%	542,490	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.32%	0.00%	174,794	16,000	10.08%	682,000	Mar 31, 2024
JEFFERIES FINANCIAL GROUP INC.	0.05%	0.00%	26,100	13,200	102.33%	101,790	Mar 31, 2024
HRT FINANCIAL LP	0.05%	0.00%	25,586	25,586	100.00%	99,000	Mar 31, 2024
MARSHALL WACE, LLP	0.16%	0.00%	85,301	85,301	100.00%	332,674	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.09%	0.00%	46,678	46,678	100.00%	182,044	Mar 31, 2024
SYNTAX RESEARCH, INC.	0.00%	0.00%	80	-	-	312	Mar 31, 2024
BANK OF MONTREAL /CAN/	0.35%	0.00%	188,067	63,770	51.30%	757,910	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	0.23%	0.00%	126,159	93,698	288.65%	492,020	Mar 31, 2024
CITIGROUP INC	0.11%	0.00%	61,420	30,612	99.36%	239,538	Mar 31, 2024

The largest Alimera Sciences shareholder by % of total assets is VELAN CAPITAL INVESTMENT MANAGEMENT LP. The company owns 13.61M shares of Alimera Sciences (ALIM), representing 24.10% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	1.92%	0.00%	1,045,460	396,506	61.10%	4,077,294	Mar 31, 2024
ANCORA ADVISORS, LLC	0.43%	0.02%	234,620	234,620	100.00%	915,018,000	Mar 31, 2024
STATE STREET CORP	0.24%	-	133,016	133,016	100.00%	518,762	Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.26%	0.01%	139,100	119,100	595.50%	542,490	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.20%	0.00%	107,101	107,101	100.00%	417,694	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	0.23%	0.00%	126,159	93,698	288.65%	492,020	Mar 31, 2024
MARSHALL WACE, LLP	0.16%	0.00%	85,301	85,301	100.00%	332,674	Mar 31, 2024
GOLDMAN SACHS GROUP INC	0.13%	-	71,758	71,758	100.00%	279,856	Mar 31, 2024
BANK OF MONTREAL /CAN/	0.35%	0.00%	188,067	63,770	51.30%	757,910	Mar 31, 2024
NORTHERN TRUST CORP	0.13%	-	73,418	59,286	419.52%	286,330	Mar 31, 2024
STONEPINE CAPITAL MANAGEMENT, LLC	7.44%	12.53%	4,051,072	51,613	1.29%	15,799,181	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.09%	0.00%	46,678	46,678	100.00%	182,044	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.69%	0.00%	378,237	46,260	13.93%	1,475,651	Mar 31, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.	0.08%	0.01%	43,400	43,400	100.00%	169,260	Mar 31, 2024
BLACKROCK INC.	0.89%	-	483,294	39,455	8.89%	1,884,847	Mar 31, 2024
CITIGROUP INC	0.11%	0.00%	61,420	30,612	99.36%	239,538	Mar 31, 2024
HRT FINANCIAL LP	0.05%	0.00%	25,586	25,586	100.00%	99,000	Mar 31, 2024
JPMORGAN CHASE & CO	0.04%	-	22,135	22,074	36186.89%	86,327	Mar 31, 2024
FIFTH LANE CAPITAL, LP	0.04%	0.07%	21,238	21,238	100.00%	82,828	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.32%	0.00%	174,794	16,000	10.08%	682,000	Mar 31, 2024

As of Mar 31 2024, Alimera Sciences's largest institutional buyer is VANGUARD GROUP INC. The company purchased 396.51K stocks of ALIM, valued at $4.08M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AIGH CAPITAL MANAGEMENT LLC	2.79%	1.78%	1,520,359	-705,709	-31.70%	5,929,400	Mar 31, 2024
WORTH VENTURE PARTNERS, LLC	-	-	-	-556,642	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	0.92%	0.00%	501,738	-414,508	-45.24%	1,956,779	Mar 31, 2024
ALTIUM CAPITAL MANAGEMENT LP	4.69%	3.94%	2,550,000	-110,000	-4.14%	9,945,000	Mar 31, 2024
CLEARLINE CAPITAL LP	3.83%	0.40%	2,085,291	-83,852	-3.87%	8,132,635	Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.	0.02%	0.00%	10,323	-29,709	-74.21%	40,260	Mar 31, 2024
HIGHTOWER ADVISORS, LLC	-	-	-	-25,091	-100.00%	-	Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP	-	-	-	-19,376	-100.00%	-	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-5,263	-100.00%	-	Mar 31, 2024
FOCUSED WEALTH MANAGEMENT, INC	-	-	-	-66	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-2	-100.00%	-	Mar 31, 2024
VELAN CAPITAL INVESTMENT MANAGEMENT LP	25.01%	24.10%	13,608,533	-	-	53,073,279	Mar 31, 2024
CALIGAN PARTNERS LP	30.93%	17.36%	16,835,154	-	-	65,657,101	Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC	5.88%	0.24%	3,198,708	-	-	12,474,961	Mar 31, 2024
SYNTAX RESEARCH, INC.	0.00%	0.00%	80	-	-	312	Mar 31, 2024
ADVISOR GROUP HOLDINGS, INC.	0.01%	-	4,065	-	-	15,853,000	Mar 31, 2024
COMERICA BANK	-	-	14	-	-	55,000	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	287	5	1.77%	1,119,000	Mar 31, 2024
MACQUARIE GROUP LTD	0.00%	-	523	523	100.00%	2	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.00%	0.00%	944	644	214.67%	3,682	Mar 31, 2024

As of Mar 31 2024, Alimera Sciences's biggest institutional seller is AIGH CAPITAL MANAGEMENT LLC. The company sold -0.71M shares of ALIM, valued at $5.93M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ANCORA ADVISORS, LLC	0.43%	0.02%	234,620	234,620	100.00%	915,018,000	Mar 31, 2024
STATE STREET CORP	0.24%	-	133,016	133,016	100.00%	518,762	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.20%	0.00%	107,101	107,101	100.00%	417,694	Mar 31, 2024
MARSHALL WACE, LLP	0.16%	0.00%	85,301	85,301	100.00%	332,674	Mar 31, 2024
GOLDMAN SACHS GROUP INC	0.13%	-	71,758	71,758	100.00%	279,856	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.09%	0.00%	46,678	46,678	100.00%	182,044	Mar 31, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.	0.08%	0.01%	43,400	43,400	100.00%	169,260	Mar 31, 2024
HRT FINANCIAL LP	0.05%	0.00%	25,586	25,586	100.00%	99,000	Mar 31, 2024
FIFTH LANE CAPITAL, LP	0.04%	0.07%	21,238	21,238	100.00%	82,828	Mar 31, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0.00%	-	666	666	100.00%	2,597	Mar 31, 2024
MACQUARIE GROUP LTD	0.00%	-	523	523	100.00%	2	Mar 31, 2024

Alimera Sciences's largest new institutional shareholder by number of shares is ANCORA ADVISORS, LLC, purchased 234.62K shares, valued at $915.02M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WORTH VENTURE PARTNERS, LLC	-	-	-	-556,642	-100.00%	-	Mar 31, 2024
HIGHTOWER ADVISORS, LLC	-	-	-	-25,091	-100.00%	-	Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP	-	-	-	-19,376	-100.00%	-	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-5,263	-100.00%	-	Mar 31, 2024
FOCUSED WEALTH MANAGEMENT, INC	-	-	-	-66	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-2	-100.00%	-	Mar 31, 2024

Alimera Sciences's largest sold out institutional shareholder by shares sold is WORTH VENTURE PARTNERS, LLC, sold -0.56M shares, valued at -, as of undefined.

Alimera Sciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.10%	260,000	-	-	Dec 29, 2023
PERRITT FUNDS INC	0.08%	10,000	-	-	Jan 31, 2024
ROYCE VALUE TRUST, INC.	0.05%	61,125	-	-	Dec 31, 2023
BRIDGEWAY FUNDS INC	0.01%	20,000	-	-	Dec 29, 2023
VANGUARD VALLEY FORGE FUNDS	0.00%	2,158	-	-	Dec 31, 2023
GABELLI EQUITY TRUST INC	0.00%	4,000	-	-	Dec 29, 2023
VANGUARD INDEX FUNDS	0.00%	1,165,354	1,018,684	694.54%	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	338,071	287,965	574.71%	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	5,583	-	-	Dec 31, 2023
SCHWAB CAPITAL TRUST	0.00%	2,627	-	-	Feb 29, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	4,666	4,666	-	Jan 31, 2024
VALIC Co I	0.00%	7,667	-	-	Feb 29, 2024
Dimensional ETF Trust	0.00%	2,812	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	1,054	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	12,485	-	-	Feb 29, 2024
EQ ADVISORS TRUST	0.00%	845	-	-	Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	336	-	-	Dec 31, 2023

Alimera Sciences's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 260.00K shares, compromising 0.10% of its total assets.

Alimera Sciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	17	-48.48%
31 Dec, 23	33	17.86%
30 Sep, 23	28	64.71%
30 Jun, 23	17	6.25%
31 Mar, 23	16	-15.79%
31 Dec, 22	19	58.33%
30 Sep, 22	12	-29.41%
30 Jun, 22	17	6.25%
31 Mar, 22	16	-11.11%
31 Dec, 21	18	-21.74%
30 Sep, 21	23	-4.17%
30 Jun, 21	24	4.35%
31 Mar, 21	23	64.29%
31 Dec, 20	14	-
30 Sep, 20	14	16.67%
30 Jun, 20	12	-14.29%
31 Mar, 20	14	-26.32%
31 Dec, 19	19	-

As of 31 Mar 24, 17 institutions are holding Alimera Sciences's shares, representing a decrease of -48.48% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	19,426,741	-59.63%
31 Dec, 23	48,123,417	1.83%
30 Sep, 23	47,256,436	1245.20%
30 Jun, 23	3,512,958	71.06%
31 Mar, 23	2,053,581	-7.87%
31 Dec, 22	2,228,972	29.72%
30 Sep, 22	1,718,341	4.39%
30 Jun, 22	1,646,103	8.52%
31 Mar, 22	1,516,822	-14.42%
31 Dec, 21	1,772,476	-9.22%
30 Sep, 21	1,952,397	-0.53%
30 Jun, 21	1,962,726	4.06%
31 Mar, 21	1,886,123	10.00%
31 Dec, 20	1,714,727	49.82%
30 Sep, 20	1,144,538	10.69%
30 Jun, 20	1,033,999	16.04%
31 Mar, 20	891,060	-31.78%
31 Dec, 19	1,306,114	-

Alimera Sciences (ALIM) has 19.43M shares outstanding as of 31 Mar 24, down -59.63% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	35.70%	0.16%
31 Dec, 23	149.89%	0.04%
30 Sep, 23	583.87%	23.40%
30 Jun, 23	49.96%	5.86%
31 Mar, 23	29.20%	2.88%
31 Dec, 22	31.86%	5.28%
30 Sep, 22	24.56%	4.44%
30 Jun, 22	23.52%	5.00%
31 Mar, 22	21.70%	3.00%
31 Dec, 21	26.88%	3.38%
30 Sep, 21	28.20%	3.96%
30 Jun, 21	26.70%	2.49%
31 Mar, 21	32.77%	2.92%
31 Dec, 20	33.51%	6.57%
30 Sep, 20	22.58%	5.35%
30 Jun, 20	20.55%	6.42%
31 Mar, 20	17.89%	4.00%
31 Dec, 19	21.15%	-

As of 31 Mar 24, Alimera Sciences is held by 35.70% institutional shareholders, representing a 0.16% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	13	-18.75%
31 Dec, 23	16	-
30 Sep, 23	16	128.57%
30 Jun, 23	7	75.00%
31 Mar, 23	4	-63.64%
31 Dec, 22	11	175.00%
30 Sep, 22	4	-42.86%
30 Jun, 22	7	133.33%
31 Mar, 22	3	50.00%
31 Dec, 21	2	-71.43%
30 Sep, 21	7	-50.00%
30 Jun, 21	14	-
31 Mar, 21	14	55.56%
31 Dec, 20	9	50.00%
30 Sep, 20	6	50.00%
30 Jun, 20	4	-33.33%
31 Mar, 20	6	-68.42%
31 Dec, 19	19	-

13 institutional shareholders have increased their position in ALIM stock as of 31 Mar 24 compared to 16 in the previous quarter (a -18.75% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	1	-87.50%
31 Dec, 23	8	14.29%
30 Sep, 23	7	40.00%
30 Jun, 23	5	150.00%
31 Mar, 23	2	-33.33%
31 Dec, 22	3	-25.00%
30 Sep, 22	4	33.33%
30 Jun, 22	3	-25.00%
31 Mar, 22	4	-42.86%
31 Dec, 21	7	75.00%
30 Sep, 21	4	-
30 Jun, 21	4	33.33%
31 Mar, 21	3	-
31 Dec, 20	-	-100.00%
30 Sep, 20	1	-50.00%
30 Jun, 20	2	-
31 Mar, 20	2	-
31 Dec, 19	-	-

1 institutional shareholders have reduced their position in ALIM stock as of 31 Mar 24 compared to 8 in the previous quarter (a -87.50% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	17	-48.48%	19,426,741	-59.63%	35.70%	0.16%	13	-18.75%	1	-87.50%
31 Dec, 23	33	17.86%	48,123,417	1.83%	149.89%	0.04%	16	-	8	14.29%
30 Sep, 23	28	64.71%	47,256,436	1245.20%	583.87%	23.40%	16	128.57%	7	40.00%
30 Jun, 23	17	6.25%	3,512,958	71.06%	49.96%	5.86%	7	75.00%	5	150.00%
31 Mar, 23	16	-15.79%	2,053,581	-7.87%	29.20%	2.88%	4	-63.64%	2	-33.33%
31 Dec, 22	19	58.33%	2,228,972	29.72%	31.86%	5.28%	11	175.00%	3	-25.00%
30 Sep, 22	12	-29.41%	1,718,341	4.39%	24.56%	4.44%	4	-42.86%	4	33.33%
30 Jun, 22	17	6.25%	1,646,103	8.52%	23.52%	5.00%	7	133.33%	3	-25.00%
31 Mar, 22	16	-11.11%	1,516,822	-14.42%	21.70%	3.00%	3	50.00%	4	-42.86%
31 Dec, 21	18	-21.74%	1,772,476	-9.22%	26.88%	3.38%	2	-71.43%	7	75.00%
30 Sep, 21	23	-4.17%	1,952,397	-0.53%	28.20%	3.96%	7	-50.00%	4	-
30 Jun, 21	24	4.35%	1,962,726	4.06%	26.70%	2.49%	14	-	4	33.33%
31 Mar, 21	23	64.29%	1,886,123	10.00%	32.77%	2.92%	14	55.56%	3	-
31 Dec, 20	14	-	1,714,727	49.82%	33.51%	6.57%	9	50.00%	-	-100.00%
30 Sep, 20	14	16.67%	1,144,538	10.69%	22.58%	5.35%	6	50.00%	1	-50.00%
30 Jun, 20	12	-14.29%	1,033,999	16.04%	20.55%	6.42%	4	-33.33%	2	-
31 Mar, 20	14	-26.32%	891,060	-31.78%	17.89%	4.00%	6	-68.42%	2	-
31 Dec, 19	19	-	1,306,114	-	21.15%	-	19	-	-	-

Alimera Sciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Apr 02, 2024	Ashman Philip	officer	President of Int'l Operations	F-InKind	Sell	12,103	$3.83	$46.35K	118,274
Jan 11, 2024	Ashman Philip	officer	President of Int'l Operations	F-InKind	Sell	2,938	$3.86	$11.34K	130,377

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 02, 2024	Ashman Philip	officer	President of Int'l Operations	F-InKind	Sell	12,103	$3.83	$46.35K	118,274
Mar 13, 2024	Werner Jason M.	officer	Chief Operating Officer	A-Award	Buy	1,800	-	-	1,800
Mar 13, 2024	Wood Todd Michael	officer	President of U.S. Operations	A-Award	Buy	125,000	-	-	125,000
Mar 13, 2024	Wood Todd Michael	officer	President of U.S. Operations	A-Award	Buy	125,000	-	-	125,000
Mar 13, 2024	EISWIRTH RICHARD S JR	officer	President and CEO	A-Award	Buy	14,700	-	-	14,700
Mar 13, 2024	Ashman Philip	officer	President of Int'l Operations	A-Award	Buy	75,000	-	-	75,000
Mar 13, 2024	Ashman Philip	officer	President of Int'l Operations	A-Award	Buy	6,800	-	-	6,800
Mar 13, 2024	Maltz Elliot	officer	Chief Financial Officer	A-Award	Buy	75,000	-	-	75,000
Mar 13, 2024	Maltz Elliot	officer	Chief Financial Officer	A-Award	Buy	75,000	-	-	75,000
Jan 11, 2024	Ashman Philip	officer	President of Int'l Operations	F-InKind	Sell	2,938	$3.86	$11.34K	130,377
Jan 04, 2024	Maltz Elliot	officer	Chief Financial Officer	A-Award	Buy	75,000	$4.32	$324.00K	75,000
Jan 04, 2024	Maltz Elliot	officer	-		Buy	-	-	-	-
Dec 13, 2023	Wood Todd Michael	officer	President of U.S. Operations	A-Award	Buy	125,000	$3.71	$463.75K	125,000
Dec 13, 2023	Wood Todd Michael	officer	-		Buy	-	-	-	-
Nov 28, 2023	SKIBSTED RUSSELL	officer	Chief Financial Officer & SVP	A-Award	Buy	50,000	$3.38	$169.00K	50,000
Nov 28, 2023	Holland David	officer	Chief Marketing Officer & SVP	A-Award	Buy	100,000	$3.38	$338.00K	100,000
Nov 28, 2023	Ashman Philip	officer	Chief Operating Officer & SVP	A-Award	Buy	147,000	$3.38	$496.86K	147,000
Nov 08, 2023	Pax Margaret	director	-	A-Award	Buy	36,713	$3.42	$125.56K	36,713
Nov 08, 2023	Pax Margaret		-		Buy	-	-	-	-
Oct 04, 2023	Morgan Adam	director, 10 percent owner		A-Award	Buy	50,000	$2.99	$149.50K	50,000

The last insider sell of Alimera Sciences's stock was made by Ashman Philip on Apr 02 2024, selling 12,103 shares at $3.83 per share (valued at $46.35K).

Alimera Sciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	1	1	100.00%
Q4 2023	15	-	-
Q3 2023	8	5	160.00%
Q2 2023	4	1	400.00%
Q1 2023	16	3	533.33%
Q4 2022	3	-	-
Q2 2022	3	-	-
Q1 2022	8	2	400.00%
Q4 2021	19	-	-
Q3 2021	1	-	-
Q2 2021	3	2	150.00%
Q1 2021	10	3	333.33%
Q4 2020	5	-	-
Q3 2020	-	1	-
Q2 2020	10	-	-
Q1 2020	10	10	100.00%
Q4 2019	36	-	-
Q3 2019	9	-	-
Q2 2019	8	2	400.00%
Q1 2019	8	21	38.10%

1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Alimera Sciences's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	1	1	100.00%
Q2 2023	3	-	-
Q1 2023	-	2	-
Q4 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	1	-
Q4 2021	9	-	-
Q3 2021	-	-	-
Q2 2021	-	1	-
Q1 2021	-	-	-
Q4 2020	2	-	-
Q3 2020	-	1	-
Q2 2020	-	-	-
Q1 2020	-	-	-
Q4 2019	6	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Alimera Sciences's stocks.

Alimera Sciences Peer Ownership

Ticker	Company
PTPI	Petros Pharmaceuticals, Inc.
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
ORGO	Organogenesis Holdings Inc.
LFCR	Lifecore Biomedical, Inc.
CYTH	Cyclo Therapeutics, Inc.
ADMP	Adamis Pharmaceuticals Corporation
DERM	Journey Medical Corporation
LSDI	Lucy Scientific Discovery Inc.
SXTC	China SXT Pharmaceuticals, Inc.

ALIM Ownership FAQ

Who Owns Alimera Sciences?

Alimera Sciences is owned by institutional shareholders (35.70%), insiders (5.97%), and public (58.34%). The largest institutional shareholder of Alimera Sciences is CALIGAN PARTNERS LP (30.93% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.10% of total shares).

Who are the major institutional shareholders of Alimera Sciences?

Alimera Sciences's major institutional shareholders are CALIGAN PARTNERS LP, VELAN CAPITAL INVESTMENT MANAGEMENT LP, STONEPINE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, and ALTIUM CAPITAL MANAGEMENT LP. The top five shareholders own together 73.95% of the company's share outstanding.

How many Alimera Sciences shareholders are there?

As of Mar 2024, there are 17 institutional shareholders of Alimera Sciences.

What percentage of Alimera Sciences is owned by CALIGAN PARTNERS LP?

CALIGAN PARTNERS LP owns 16.84M shares of Alimera Sciences, representing 30.93% of the company's total shares outstanding, valued at $65.66M (as of Mar 2024).

What percentage of Alimera Sciences is owned by VELAN CAPITAL INVESTMENT MANAGEMENT LP?

As of Mar 2024, VELAN CAPITAL INVESTMENT MANAGEMENT LP holds 13.61M shares of Alimera Sciences (ALIM), compromising 25.01% of the company, valued at $53.07M.

What percentage of Alimera Sciences is owned by STONEPINE CAPITAL MANAGEMENT, LLC?

STONEPINE CAPITAL MANAGEMENT, LLC is the third largest holder of Alimera Sciences. The company owns 4.05M of the company's shares outstanding (worth $15.8M).